{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:26:42Z","timestamp":1778261202845,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00853-2","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T09:19:50Z","timestamp":1746523190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glycemic control and prostate antigen levels in individuals with diabetes based on NHANES data"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiao","family":"Huo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"issue":"4","key":"853_CR1","first-page":"e58680","volume":"16","author":"A Bharti","year":"2024","unstructured":"Bharti, A., Shekhar, R., Prakash, P., Kumari, S. & Kumar, S. Poor glycemic control affecting screening of prostate carcinoma. Cureus 16 (4), e58680 (2024).","journal-title":"Cureus"},{"issue":"1","key":"853_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1515\/cclm-2020-0145","volume":"59","author":"MC Bernal-Soriano","year":"2020","unstructured":"Bernal-Soriano, M. C. et al. Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis. Clin. Chem. Lab. Med. 59 (1), 11\u201326 (2020).","journal-title":"Clin. Chem. Lab. Med."},{"key":"853_CR3","doi-asserted-by":"crossref","unstructured":"Franko, A. et al. Transcript levels of Aldo-Keto reductase family 1 subfamily C (AKR1C) are increased in prostate tissue of patients with type 2 diabetes. J. Pers. Med. 10(3), 73 (2020).","DOI":"10.3390\/jpm10030124"},{"key":"853_CR4","doi-asserted-by":"crossref","unstructured":"Kasper, J. S. & Giovannucci, E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American association for Cancer research, cosponsored by the American society of preventive oncology. ;15(11):2056\u20132062. (2006).","DOI":"10.1158\/1055-9965.EPI-06-0410"},{"issue":"3","key":"853_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.urolonc.2013.09.017","volume":"32","author":"J Romero Otero","year":"2014","unstructured":"Romero Otero, J., Garcia Gomez, B., Campos Juanatey, F. & Touijer, K. A. Prostate cancer biomarkers: an update. Urol. Oncol. 32 (3), 252\u2013260 (2014).","journal-title":"Urol. Oncol."},{"issue":"16","key":"853_CR6","first-page":"5077","volume":"22","author":"B Zhou","year":"2018","unstructured":"Zhou, B. et al. Correlations of glucose metabolism, insulin resistance and inflammatory factors with symptom score of patients with benign prostatic hyperplasia. Eur. Rev. Med. Pharmacol. Sci. 22 (16), 5077\u20135081 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"853_CR7","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/j.clgc.2022.09.007","volume":"21","author":"A Satir","year":"2023","unstructured":"Satir, A. & Demirci, H. Total prostate specific antigen in prostate Cancer screening in hyperglycemic individuals. Clin. Genitourin. Cancer. 21 (2), e53\u2013e7 (2023).","journal-title":"Clin. Genitourin. Cancer"},{"key":"853_CR8","doi-asserted-by":"crossref","unstructured":"M\u00fcller, H., Raum, E., Rothenbacher, D., Stegmaier, C. & Brenner, H. Association of diabetes and body mass index with levels of prostate-specific antigen: implications for correction of prostate-specific antigen cutoff values? Cancer Epidemiol. Biomarkers Prev. 18(5), 1350\u20131356 (2009).","DOI":"10.1158\/1055-9965.EPI-08-0794"},{"issue":"11","key":"853_CR9","doi-asserted-by":"publisher","first-page":"e1914689","DOI":"10.1001\/jamanetworkopen.2019.14689","volume":"2","author":"K Beckmann","year":"2019","unstructured":"Beckmann, K. et al. Association between antidiabetic medications and Prostate-Specific antigen levels and biopsy results. JAMA Netw. Open. 2 (11), e1914689 (2019).","journal-title":"JAMA Netw. Open."},{"issue":"2\u20133","key":"853_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2010.05.042","volume":"641","author":"A Vikram","year":"2010","unstructured":"Vikram, A., Jena, G. & Ramarao, P. Insulin-resistance and benign prostatic hyperplasia: the connection. Eur. J. Pharmacol. 641 (2\u20133), 75\u201381 (2010).","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"853_CR11","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/labinvest.2011.87","volume":"91","author":"C Ye","year":"2011","unstructured":"Ye, C. et al. Diabetes causes multiple genetic alterations and downregulates expression of DNA repair genes in the prostate. Lab. Invest. 91 (9), 1363\u20131374 (2011).","journal-title":"Lab. Invest."},{"issue":"51","key":"853_CR12","doi-asserted-by":"publisher","first-page":"e9427","DOI":"10.1097\/MD.0000000000009427","volume":"96","author":"JS Park","year":"2017","unstructured":"Park, J. S., Lee, K. S., Ham, W. S., Chung, B. H. & Koo, K. C. Impact of Metformin on serum prostate-specific antigen levels: data from the National health and nutrition examination survey 2007 to 2008. Medicine 96 (51), e9427 (2017).","journal-title":"Medicine"},{"issue":"2","key":"853_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4236\/jct.2017.82007","volume":"8","author":"X Liu","year":"2017","unstructured":"Liu, X. et al. Statins and Metformin use is associated with lower PSA levels in prostate Cancer patients presenting for radiation therapy. J. cancer Therapy. 8 (2), 73\u201385 (2017).","journal-title":"J. cancer Therapy"},{"key":"853_CR14","doi-asserted-by":"crossref","unstructured":"Ahn, H. K., Lee, Y. H. & Koo, K. C. Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review. International journal of molecular sciences. ;21(22). (2020).","DOI":"10.3390\/ijms21228540"},{"issue":"1","key":"853_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5534\/wjmh.210001","volume":"40","author":"CH Tseng","year":"2022","unstructured":"Tseng, C. H. The effect of Metformin on male reproductive function and prostate: an updated review. World J. Men\u2019s Health. 40 (1), 11\u201329 (2022).","journal-title":"World J. Men\u2019s Health"},{"issue":"1","key":"853_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3109\/07435800.2014.934961","volume":"40","author":"P Jian Gang","year":"2015","unstructured":"Jian Gang, P., Mo, L., Lu, Y., Runqi, L. & Xing, Z. Diabetes mellitus and the risk of prostate cancer: an update and cumulative meta-analysis. Endocr. Res. 40 (1), 54\u201361 (2015).","journal-title":"Endocr. Res."},{"issue":"163","key":"853_CR17","first-page":"1","volume":"2","author":"L Borrud","year":"2014","unstructured":"Borrud, L. et al. National health and nutrition examination survey: National youth fitness survey plan, operations, and analysis, 2012. Data Evaluation Methods Res. 2 (163), 1\u201324 (2014). Vital and health statistics Series.","journal-title":"Data Evaluation Methods Res."},{"issue":"Suppl 2","key":"853_CR18","first-page":"B21","volume":"23","author":"M Shichiri","year":"2000","unstructured":"Shichiri, M., Kishikawa, H., Ohkubo, Y. & Wake, N. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 23 (Suppl 2), B21\u2013B29 (2000).","journal-title":"Diabetes Care"},{"issue":"5","key":"853_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1365-2125.1999.00092.x","volume":"48","author":"P King","year":"1999","unstructured":"King, P., Peacock, I. & Donnelly, R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br. J. Clin. Pharmacol. 48 (5), 643\u2013648 (1999).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"853_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-015-0285-1","volume":"14","author":"P Wang","year":"2015","unstructured":"Wang, P. et al. HbA1c below 7% as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis. Cardiovasc. Diabetol. 14, 124 (2015).","journal-title":"Cardiovasc. Diabetol."},{"issue":"8","key":"853_CR21","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2337\/diacare.24.8.1384","volume":"24","author":"PM Trief","year":"2001","unstructured":"Trief, P. M., Himes, C. L., Orendorff, R. & Weinstock, R. S. The marital relationship and psychosocial adaptation and glycemic control of individuals with diabetes. Diabetes Care. 24 (8), 1384\u20131389 (2001).","journal-title":"Diabetes Care"},{"issue":"5","key":"853_CR22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1177\/1090198117752783","volume":"45","author":"L Haines","year":"2018","unstructured":"Haines, L., Coppa, N., Harris, Y., Wisnivesky, J. P. & Lin, J. J. The impact of partnership status on diabetes control and Self-Management behaviors. Health Educ. Behavior: Official Publication Soc. Public. Health Educ. 45 (5), 668\u2013671 (2018).","journal-title":"Health Educ. Behavior: Official Publication Soc. Public. Health Educ."},{"issue":"2","key":"853_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/CEJ.0b013e3283656394","volume":"23","author":"AA Onitilo","year":"2014","unstructured":"Onitilo, A. A. et al. Type 2 diabetes mellitus, glycemic control, and cancer risk. Eur. J. cancer Prevention: Official J. Eur. Cancer Prev. Organisation (ECP). 23 (2), 134\u2013140 (2014).","journal-title":"Eur. J. cancer Prevention: Official J. Eur. Cancer Prev. Organisation (ECP)"},{"issue":"8","key":"853_CR24","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/aje\/kwp003","volume":"169","author":"KM Waters","year":"2009","unstructured":"Waters, K. M. et al. Association of diabetes with prostate cancer risk in the multiethnic cohort. Am. J. Epidemiol. 169 (8), 937\u2013945 (2009).","journal-title":"Am. J. Epidemiol."},{"issue":"9","key":"853_CR25","doi-asserted-by":"publisher","first-page":"e104789","DOI":"10.1371\/journal.pone.0104789","volume":"9","author":"J Park","year":"2014","unstructured":"Park, J. et al. Poor glycemic control of diabetes mellitus is associated with higher risk of prostate cancer detection in a biopsy population. PloS One. 9 (9), e104789 (2014).","journal-title":"PloS One"},{"issue":"3","key":"853_CR26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.juro.2014.08.115","volume":"193","author":"AV Sarma","year":"2015","unstructured":"Sarma, A. V. et al. Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes. J. Urol. 193 (3), 786\u2013793 (2015).","journal-title":"J. Urol."},{"issue":"3","key":"853_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.prnil.2017.02.004","volume":"5","author":"HA Atalay","year":"2017","unstructured":"Atalay, H. A. et al. Impact of poor glycemic control of type 2 diabetes mellitus on serum prostate-specific antigen concentrations in men. Prostate Int. 5 (3), 104\u2013109 (2017).","journal-title":"Prostate Int."},{"issue":"3","key":"853_CR28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2174\/1573399813666170117113519","volume":"14","author":"A Ainahi","year":"2018","unstructured":"Ainahi, A. et al. Prostate-specific antigen levels in Moroccan diabetic males: A Cross-sectional study. Curr. Diabetes. Rev. 14 (3), 286\u2013290 (2018).","journal-title":"Curr. Diabetes. Rev."},{"issue":"11","key":"853_CR29","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1111\/j.1464-410X.2011.10225.x","volume":"108","author":"HC Choi","year":"2011","unstructured":"Choi, H. C. et al. The illusion of prostate-specific antigen decline in patients with metabolic syndrome and insulin resistance. BJU Int. 108 (11), 1756\u20131761 (2011).","journal-title":"BJU Int."},{"issue":"2","key":"853_CR30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ejca.2010.09.023","volume":"47","author":"K Ohwaki","year":"2011","unstructured":"Ohwaki, K., Endo, F., Muraishi, O. & Yano, E. Relationship between changes in haemoglobin A1C and prostate-specific antigen in healthy men. Eur. J. cancer (Oxford England: 1990). 47 (2), 262\u2013266 (2011).","journal-title":"Eur. J. cancer (Oxford England: 1990)"},{"issue":"4\u20135","key":"853_CR31","first-page":"261","volume":"82","author":"Z Wang","year":"2011","unstructured":"Wang, Z. & Olumi, A. F. Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia. Differ. Res. Biol. Divers. 82 (4\u20135), 261\u2013271 (2011).","journal-title":"Differ. Res. Biol. Divers."},{"key":"853_CR32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.critrevonc.2016.11.003","volume":"108","author":"SC Chang","year":"2016","unstructured":"Chang, S. C. & Yang, W. V. Hyperglycemia, tumorigenesis, and chronic inflammation. Crit. Rev. Oncol. Hematol. 108, 146\u2013153 (2016).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"853_CR33","doi-asserted-by":"crossref","unstructured":"Franko, A. et al. Increased expressions of matrix metalloproteinases (MMPs) in prostate cancer tissues of men with type 2 diabetes. Biomedicines 8(11), 530 (2020).","DOI":"10.3390\/biomedicines8110507"},{"key":"853_CR34","doi-asserted-by":"crossref","unstructured":"AlZaim, I. et al. Thromboinflammatory processes at the nexus of metabolic dysfunction and prostate cancer: the emerging role of periprostatic adipose tissue. Cancers 14(7), 1773 (2022).","DOI":"10.3390\/cancers14071679"},{"issue":"1","key":"853_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7314\/APJCP.2012.13.1.001","volume":"13","author":"DA McGrowder","year":"2012","unstructured":"McGrowder, D. A., Jackson, L. A. & Crawford, T. V. Prostate cancer and metabolic syndrome: is there a link? Asian Pac. J. cancer Prevention: APJCP. 13 (1), 1\u201313 (2012).","journal-title":"Asian Pac. J. cancer Prevention: APJCP"},{"issue":"2","key":"853_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12672-015-0238-x","volume":"7","author":"H Rhee","year":"2016","unstructured":"Rhee, H., Vela, I. & Chung, E. Metabolic syndrome and prostate cancer: a review of complex interplay amongst various endocrine factors in the pathophysiology and progression of prostate Cancer. Horm. cancer. 7 (2), 75\u201383 (2016).","journal-title":"Horm. cancer"},{"issue":"1","key":"853_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.prnil.2015.08.001","volume":"4","author":"D Parikesit","year":"2016","unstructured":"Parikesit, D., Mochtar, C. A., Umbas, R. & Hamid, A. R. The impact of obesity towards prostate diseases. Prostate Int. 4 (1), 1\u20136 (2016).","journal-title":"Prostate Int."},{"key":"853_CR38","doi-asserted-by":"crossref","unstructured":"Fujita, K. et al. Obesity, inflammation, and prostate cancer. J. Clin. Med. 8(2), 153 (2019).","DOI":"10.3390\/jcm8020201"},{"key":"853_CR39","doi-asserted-by":"publisher","first-page":"843458","DOI":"10.3389\/fcell.2022.843458","volume":"10","author":"AP Sousa","year":"2022","unstructured":"Sousa, A. P. et al. The impact of metabolic syndrome and type 2 diabetes mellitus on prostate Cancer. Front. Cell. Dev. Biology. 10, 843458 (2022).","journal-title":"Front. Cell. Dev. Biology"},{"key":"853_CR40","doi-asserted-by":"publisher","first-page":"697264","DOI":"10.1155\/2014\/697264","volume":"2014","author":"JJ Lee","year":"2014","unstructured":"Lee, J. J., Beretvas, S. N. & Freeland-Graves, J. H. Abdominal adiposity distribution in diabetic\/prediabetic and nondiabetic populations: a meta-analysis. J. Obes. 2014, 697264 (2014).","journal-title":"J. Obes."},{"key":"853_CR41","doi-asserted-by":"publisher","first-page":"554078","DOI":"10.3389\/fendo.2021.554078","volume":"12","author":"R Cannarella","year":"2021","unstructured":"Cannarella, R., Condorelli, R. A., Barbagallo, F., La Vignera, S. & Calogero, A. E. Endocrinology of the aging prostate: current concepts. Front. Endocrinol. 12, 554078 (2021).","journal-title":"Front. Endocrinol."},{"issue":"1","key":"853_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1043659613504112","volume":"25","author":"G Cosansu","year":"2014","unstructured":"Cosansu, G. & Erdogan, S. Influence of psychosocial factors on self-care behaviors and glycemic control in Turkish patients with type 2 diabetes mellitus. J. Transcultural Nursing: Official J. Transcultural Nurs. Soc. 25 (1), 51\u201359 (2014).","journal-title":"J. Transcultural Nursing: Official J. Transcultural Nurs. Soc."},{"issue":"5","key":"853_CR43","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1037\/0278-6133.18.5.482","volume":"18","author":"AA Stone","year":"1999","unstructured":"Stone, A. A., Mezzacappa, E. S., Donatone, B. A. & Gonder, M. Psychosocial stress and social support are associated with prostate-specific antigen levels in men: results from a community screening program. Health Psychology: Official J. Div. Health Psychol. Am. Psychol. Association. 18 (5), 482\u2013486 (1999).","journal-title":"Health Psychology: Official J. Div. Health Psychol. Am. Psychol. Association"},{"issue":"5","key":"853_CR44","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10552-019-01159-1","volume":"30","author":"AG Cuevas","year":"2019","unstructured":"Cuevas, A. G. et al. Placing prostate cancer disparities within a psychosocial context: challenges and opportunities for future research. Cancer Causes Control: CCC. 30 (5), 443\u2013456 (2019).","journal-title":"Cancer Causes Control: CCC"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00853-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00853-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00853-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T09:20:00Z","timestamp":1746523200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00853-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["853"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00853-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5674422\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study utilized data from the NHANES, which was approved by the Institutional Review Board (IRB) of the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC). Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided informed consent for the publication of their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors confirm that there are no conflicts of interest regarding the publication of this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"15828"}}